ALBIREO PHARMA, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q4 2010 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Albireo Pharma, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q4 2010 to Q3 2022.
  • Albireo Pharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2022 was -$37.8M, a 166% decline year-over-year.
  • Albireo Pharma, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2022 was -$131M, a 174% decline year-over-year.
  • Albireo Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$34M, a 68.4% increase from 2020.
  • Albireo Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$108M, a 71.6% decline from 2019.
  • Albireo Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2019 was -$62.7M, a 36% decline from 2018.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 -$131M -$37.8M -$94.9M -166% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-08
Q2 2022 -$36.3M -$39.9M -$3.53M -9.69% Apr 1, 2022 Jun 30, 2022 10-Q 2022-11-08
Q1 2022 -$32.7M -$42.4M +$1.3M +2.97% Jan 1, 2022 Mar 31, 2022 10-Q 2022-11-08
Q4 2021 -$34M -$11M +$13.8M +55.8% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-01
Q3 2021 -$47.9M $57.1M +$87.8M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$136M -$36.4M -$15.8M -76.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-08
Q1 2021 -$120M -$43.7M -$12.2M -38.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-08
Q4 2020 -$108M -$24.8M -$17.3M -230% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-01
Q3 2020 -$90.4M -$30.7M -$8.83M -40.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$81.5M -$20.6M -$3.98M -23.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-04
Q1 2020 -$77.5M -$31.5M -$14.8M -89% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-04
Q4 2019 -$62.7M -$7.52M +$8.34M +52.6% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$71.1M -$21.9M -$7.89M -56.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$63.2M -$16.6M -$2.02M -13.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-05
Q1 2019 -$61.1M -$16.7M -$15M -929% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-05
Q4 2018 -$46.1M -$15.9M -$10.8M -214% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-02
Q3 2018 -$35.3M -$14M -$7.51M -115% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 -$27.8M -$14.6M -$8.43M -136% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-06
Q1 2018 -$19.4M -$1.62M +$5.05M +75.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-06
Q4 2017 -$24.4M -$5.06M +$6.16M +54.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-06
Q3 2017 -$30.6M -$6.51M -$2.48M -61.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$28.1M -$6.18M -$8.32M -389% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$19.8M -$6.67M -$3.43M -106% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$16.4M -$11.2M -$8.01M -249% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-27
Q3 2016 -$8.35M -$4.03M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 $2.14M +$8.6M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-21
Q1 2016 -$3.24M +$1.12M +25.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 -$3.22M +$1.47M +31.4% Oct 1, 2015 Dec 31, 2015 10-Q 2016-02-16
Q2 2015 -$17.8M -$6.46M -$3.26M -102% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$14.5M -$4.36M +$1.84M +29.7% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$16.4M -$4.69M -$2.24M -91.9% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-16
Q3 2014 -$14.1M -$2.29M -$1.47M -180% Jul 1, 2014 Sep 30, 2014 10-K 2015-12-22
Q2 2014 -$12.7M -$3.2M +$6.43M +66.7% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 -$19.1M -$6.2M -$978K -18.7% Jan 1, 2014 Mar 31, 2014 10-Q/A 2015-06-01
Q4 2013 -$18.1M -$2.44M +$1.23M +33.4% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-12
Q3 2013 -$19.3M -$815K +$5.06M +86.1% Jul 1, 2013 Sep 30, 2013 10-K 2013-12-20
Q2 2013 -$24.4M -$9.63M -$3.58M -59.2% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
Q1 2013 -$20.8M -$5.22M -$904K -20.9% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 -$19.9M -$3.67M +$832K +18.5% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-10
Q3 2012 -$20.7M -$5.88M -$10M -242% Jul 1, 2012 Sep 30, 2012 10-K 2013-12-20
Q2 2012 -$10.7M -$6.05M -$2.08M -52.3% Apr 1, 2012 Jun 30, 2012 10-K 2013-12-20
Q1 2012 -$8.66M -$4.32M +$1.13M +20.7% Jan 1, 2012 Mar 31, 2012 10-K 2013-12-20
Q4 2011 -$9.78M -$4.5M +$808K +15.2% Oct 1, 2011 Dec 31, 2011 10-K 2013-12-20
Q3 2011 -$10.6M $4.13M Jul 1, 2011 Sep 30, 2011 10-K 2012-12-21
Q2 2011 -$3.97M Apr 1, 2011 Jun 30, 2011 10-K 2012-12-21
Q1 2011 -$5.44M Jan 1, 2011 Mar 31, 2011 10-K 2012-12-21
Q4 2010 -$5.31M Oct 1, 2010 Dec 31, 2010 10-K 2012-12-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.